Cargando…

Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland

BACKGROUND: Patients with primary Sjögren's syndrome (pSS) produce functional IgG against cholinoreceptor of exocrine glands modifying their activity. The aim of the present work was to demonstrate pSS IgG antibodies (pSS IgG) interacting with M(3) muscarinic acetylcholine receptors (mAChR) of...

Descripción completa

Detalles Bibliográficos
Autores principales: Passafaro, Daniela, Sterin-Borda, Leonor, Reina, Silvia, Borda, Enri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177389/
https://www.ncbi.nlm.nih.gov/pubmed/22013477
_version_ 1782212295269548032
author Passafaro, Daniela
Sterin-Borda, Leonor
Reina, Silvia
Borda, Enri
author_facet Passafaro, Daniela
Sterin-Borda, Leonor
Reina, Silvia
Borda, Enri
author_sort Passafaro, Daniela
collection PubMed
description BACKGROUND: Patients with primary Sjögren's syndrome (pSS) produce functional IgG against cholinoreceptor of exocrine glands modifying their activity. The aim of the present work was to demonstrate pSS IgG antibodies (pSS IgG) interacting with M(3) muscarinic acetylcholine receptors (mAChR) of rats submandibular glands that alter mucin release and production via phospholipase C (PLC) and cyclooxigenase-2 (COX-2) pathways. METHODS: Mucin release and production of prostaglandin E2 (PGE2), and total inositol phosphates (InsP) were measured in rat submandibular gland in the presence of pSS IgG auto antibodies. RESULTS: The auto antibodies interacting with M3 mAChR decreased mucin release and production through stimulation of PLC and COX-2. This stimulation leads to an incremental increase in InsP production and in PGE2 generation, inducing signalling through the prostaglandin membrane receptors subtype 2 (EP2). Moreover, the decrease in mucin production had negative correlation with PGE(2) generation and InsP accumulation. CONCLUSION: IgG in patients with pSS could play an important role in the pathoetiology of dry mouth, decreasing the salivary mucin through the production of proinflammatory substances and leading to the reduction in the protection of the oral tissues.
format Online
Article
Text
id pubmed-3177389
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-31773892011-10-19 Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland Passafaro, Daniela Sterin-Borda, Leonor Reina, Silvia Borda, Enri Dent Res J (Isfahan) Original Article BACKGROUND: Patients with primary Sjögren's syndrome (pSS) produce functional IgG against cholinoreceptor of exocrine glands modifying their activity. The aim of the present work was to demonstrate pSS IgG antibodies (pSS IgG) interacting with M(3) muscarinic acetylcholine receptors (mAChR) of rats submandibular glands that alter mucin release and production via phospholipase C (PLC) and cyclooxigenase-2 (COX-2) pathways. METHODS: Mucin release and production of prostaglandin E2 (PGE2), and total inositol phosphates (InsP) were measured in rat submandibular gland in the presence of pSS IgG auto antibodies. RESULTS: The auto antibodies interacting with M3 mAChR decreased mucin release and production through stimulation of PLC and COX-2. This stimulation leads to an incremental increase in InsP production and in PGE2 generation, inducing signalling through the prostaglandin membrane receptors subtype 2 (EP2). Moreover, the decrease in mucin production had negative correlation with PGE(2) generation and InsP accumulation. CONCLUSION: IgG in patients with pSS could play an important role in the pathoetiology of dry mouth, decreasing the salivary mucin through the production of proinflammatory substances and leading to the reduction in the protection of the oral tissues. Medknow Publications Pvt Ltd 2011 /pmc/articles/PMC3177389/ /pubmed/22013477 Text en Copyright: © Dental Research Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Passafaro, Daniela
Sterin-Borda, Leonor
Reina, Silvia
Borda, Enri
Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland
title Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland
title_full Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland
title_fullStr Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland
title_full_unstemmed Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland
title_short Cholinergic Autoantibodies from Primary Sjögren's Syndrome Inhibit Mucin Production via Phospholipase C and Cyclooxygenase-2 In the Rat Submandibular Gland
title_sort cholinergic autoantibodies from primary sjögren's syndrome inhibit mucin production via phospholipase c and cyclooxygenase-2 in the rat submandibular gland
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177389/
https://www.ncbi.nlm.nih.gov/pubmed/22013477
work_keys_str_mv AT passafarodaniela cholinergicautoantibodiesfromprimarysjogrenssyndromeinhibitmucinproductionviaphospholipasecandcyclooxygenase2intheratsubmandibulargland
AT sterinbordaleonor cholinergicautoantibodiesfromprimarysjogrenssyndromeinhibitmucinproductionviaphospholipasecandcyclooxygenase2intheratsubmandibulargland
AT reinasilvia cholinergicautoantibodiesfromprimarysjogrenssyndromeinhibitmucinproductionviaphospholipasecandcyclooxygenase2intheratsubmandibulargland
AT bordaenri cholinergicautoantibodiesfromprimarysjogrenssyndromeinhibitmucinproductionviaphospholipasecandcyclooxygenase2intheratsubmandibulargland